Determinants of change in resting energy expenditure in patients with stage III/IV colorectal cancer

被引:21
|
作者
Purcell, Sarah A. [1 ]
Wallengren, Ola [2 ]
Baracos, Vickie E. [3 ]
Lundholm, Kent [4 ,5 ]
Iresjo, Britt-Marie [4 ,5 ]
Chu, Quincy S. C. [3 ]
Ghosh, Sunita S. [3 ]
Prado, Carla M. [1 ]
机构
[1] Univ Alberta, Fac Agr Life & Environm Sci, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada
[2] Sahlgrens Univ Hosp, Clin Nutr Unit, Gothenburg, Sweden
[3] Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB, Canada
[4] Univ Gothenburg, Inst Clin Sci, Dept Surg, Surg Metab Res Lab, Gothenburg, Sweden
[5] Univ Gothenburg, Sahlgrenska Univ Hosp, Gothenburg, Sweden
基金
加拿大健康研究院; 瑞典研究理事会;
关键词
Energy expenditure; Cancer; Neoplasm; Body composition; Energy metabolism; BODY-COMPOSITION; PHYSICAL-ACTIVITY; PALLIATIVE CARE; RECOMBINANT ERYTHROPOIETIN; SYSTEMIC INFLAMMATION; PERFORMANCE STATUS; EXERCISE CAPACITY; METABOLIC-RATE; CACHEXIA; MASS;
D O I
10.1016/j.clnu.2018.12.038
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Resting energy expenditure (REE) is variable in cancer and might be influenced by changes in tumor burden, systemic inflammation, and body composition. The objective of this study was to assess REE change and the predictors of such in patients with stage Ill or IV colorectal cancer. Methods: REE was measured via indirect calorimetry and fat mass and fat-free mass (FFM) were assessed using dual X-ray absorptiometry as part of a unique analysis of two studies. C-reactive protein (CRP) was measured as an inflammatory marker. Linear regression was used to assess the determinants of REE at baseline and REE change, with days between baseline and follow-up measures included as a covariate. Results: One-hundred and nine patients were included at baseline (59.6% male; 67 +/- 12 years; body mass index 24.1 +/- 4.3 kg/m(2) ); 49 had follow-up data (61.2% male: 65 +/- 12 years: body mass index 25.4 +/- 4.3 kg/m(2) ), with median follow-up of 119 days (interquartile range: 113-127 days). At baseline. age, FFM, and CRP explained 68.9% of the variability in REE. A wide variability in REE change over time was observed, ranging from -156 to 370 kcal/day, or -13.0 to 15.7%/100 days. CRP change (1.7 +/- 0.4 mg/ L, p < 0.001) and stage (81.3 +/- 38.7, p = 0.042) predicted REE change in multivariate analysis, controlling for age, FFM change, and days between visits (R-2 : 0.417 +/- 88.2, p < 0.001). Conclusions: Age, FFM, and CRP predicted REE at a single time point. REE change was highly variable and explained by inflammation and stage. Future research should investigate the validity and feasibility of incorporating these measures into energy needs recommendations. (C) 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 50 条
  • [21] Neuroendocrine differentiation in stage III-IV colorectal cancer.
    Schindler, I
    Grabowski, P
    Anagnostopoulos, I
    Foss, HD
    Berger, G
    Schoenfelder, J
    Riecken, EO
    Scheruebl, H
    GASTROENTEROLOGY, 2000, 118 (04) : A511 - A511
  • [22] DETERMINANTS OF RESTING ENERGY-EXPENDITURE IN YOUNG-CHILDREN
    GORAN, MI
    KASKOUN, M
    JOHNSON, R
    JOURNAL OF PEDIATRICS, 1994, 125 (03): : 362 - 367
  • [23] Resting energy expenditure and body composition in patients with newly detected cancer
    Cao, Dong-xing
    Wu, Guo-hao
    Zhang, Bo
    Quan, Ying-jun
    Wei, Jia
    Jin, Huan
    Jiang, Yi
    Yang, Zi-ang
    CLINICAL NUTRITION, 2010, 29 (01) : 72 - 77
  • [24] Comment on "Accuracy of Resting Energy Expenditure Predictive Equations in Patients With Cancer"
    Pires de Souza, Micheline Tereza
    Singer, Pierre
    Ozorio, Gislaine Aparecida
    Ferreira Alves-Almeida, Maria Manuela
    Waitzberg, Dan L.
    NUTRITION IN CLINICAL PRACTICE, 2019, 34 (06) : 940 - 941
  • [25] RESTING ENERGY-EXPENDITURE - DETERMINANTS OF DAY TO DAY VARIATION
    WEISSMAN, C
    KEMPER, M
    ASKANAZI, J
    HYMAN, AI
    KINNEY, JM
    ANESTHESIOLOGY, 1986, 65 (3A) : A86 - A86
  • [26] ENERGY-EXPENDITURE IN MALNOURISHED PATIENTS WITH COLORECTAL-CANCER
    DEMPSEY, DT
    KNOX, LS
    MULLEN, JL
    MILLER, C
    FEURER, ID
    BUZBY, GP
    ARCHIVES OF SURGERY, 1986, 121 (07) : 789 - 795
  • [27] Incidence of and risk factors for hospitalizations from chemotherapy among patients with stage III and stage IV colorectal cancer.
    Falconi, April
    Fishman, Ezra
    Barron, John
    Eleff, Michael
    Fisch, Michael Jordan
    Chi, Winnie
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Prognostic determinants in surgical critial patients undergoing emergency surgery for Stage III or higher colorectal cancer
    Hyun Ho Kim
    Sanguk Hwang
    Jinbeom Cho
    Langenbeck's Archives of Surgery, 410 (1)
  • [29] SAFETY OF ADJUVANT FOLFOX FOR JAPANESE PATIENTS WITH STAGE III/IV COLORECTAL CANCER FOLLOWING CURATIVE RESECTION
    Kawamoto, Yasuyuki
    Yoshino, Takayuki
    Fukushima, Hiraku
    Hara, Hiroki
    Kojima, Takashi
    Oono, Yasuhiro
    Fuse, Nozomu
    Ikematsu, Hiroaki
    Yano, Tomonori
    Minashi, Keiko
    Tahara, Makoto
    Kaneko, Kazuhiro
    Doi, Toshihiko
    Ohtsu, Atsushi
    ANNALS OF ONCOLOGY, 2010, 21 : 15 - 15
  • [30] Resting energy expenditure in peritoneal dialysis patients
    Bazanelli, Ana P.
    Kamimura, Maria A.
    Barbosa da Silva, Camila
    Avesani, Carla M.
    Garcia Lopes, Miriam G.
    Manfredi, Silvia R.
    Draibe, Sergio A.
    Cuppari, Lilian
    PERITONEAL DIALYSIS INTERNATIONAL, 2006, 26 (06): : 697 - 704